Jani AB - Search Results

1

Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era.

Jani AB, Vaida F, Hanks G, Asbell S, Sartor O, Moul JW, Roach M 3rd, Brachman D, Kalokhe U, Muller-Runkel R, Ray P, Ignacio L, Awan A, Weichselbaum RR, Vijayakumar S. Jani AB, et al. Int J Cancer. 2001 Dec 20;96(6):363-71. doi: 10.1002/ijc.1035. Int J Cancer. 2001. PMID: 11745507

2

Volumetric visualization of head and neck CT data for treatment planning.

Lee JS, Jani AB, Pelizzari CA, Haraf DJ, Vokes EE, Weichselbaum RR, Chen GT. Lee JS, et al. Among authors: jani ab. Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):693-703. doi: 10.1016/s0360-3016(99)00042-5. Int J Radiat Oncol Biol Phys. 1999. PMID: 10348301

3

PSA-based outcome analysis after radiation therapy for prostate cancer: a new definition of biochemical failure after intervention.

Jani AB, Chen MH, Vaida F, Ignacio L, Awan A, Weichselbaum RR, Vijayakumar S. Jani AB, et al. Urology. 1999 Oct;54(4):700-5. doi: 10.1016/s0090-4295(99)00229-0. Urology. 1999. PMID: 10510931

4

Equivalent racial outcome after conformal radiotherapy for prostate cancer: a single departmental experience.

Connell PP, Ignacio L, Haraf D, Awan AM, Halpern H, Abdalla I, Nautiyal J, Jani AB, Weichselbaum RR, Vijayakumar S. Connell PP, et al. Among authors: jani ab. J Clin Oncol. 2001 Jan 1;19(1):54-61. doi: 10.1200/JCO.2001.19.1.54. J Clin Oncol. 2001. PMID: 11134195

5

Sentinel lymph node versus axillary lymph node dissection for early-stage breast carcinoma: a comparison using a utility-adjusted number needed to treat analysis.

Jani AB, Basu A, Heimann R, Hellman S. Jani AB, et al. Cancer. 2003 Jan 15;97(2):359-66. doi: 10.1002/cncr.11081. Cancer. 2003. PMID: 12518360 Free article.

6

Evolution of toxicity after conformal radiotherapy for prostate cancer.

Abdalla I, Ignacio L, Vaida F, Mei-Hsu, Awan A, Jani A, Mamo C, Weichselbaum RR, Vijayakumar S. Abdalla I, et al. Prostate Cancer Prostatic Dis. 2002;5(4):296-303. doi: 10.1038/sj.pcan.4500608. Prostate Cancer Prostatic Dis. 2002. PMID: 12627215

7

Biological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysis.

Jani AB, Hand CM, Pelizzari CA, Roeske JC, Krauz L, Vijayakumar S. Jani AB, et al. BMC Cancer. 2003 May 13;3:16. doi: 10.1186/1471-2407-3-16. BMC Cancer. 2003. PMID: 12744725 Free PMC article.

8

Impact of hormone therapy when combined with external beam radiotherapy for early-stage, intermediate-, or high-risk prostate cancer.

Jani AB, Basu A, Abdalla I, Connell PP, Krauz L, Vijayakumar S. Jani AB, et al. Am J Clin Oncol. 2003 Aug;26(4):382-5. doi: 10.1097/01.COC.0000026483.80660.94. Am J Clin Oncol. 2003. PMID: 12902891

9

Organ motion and IMRT in prostate cancer therapy.

Jani AB. Jani AB. Cancer J. 2003 Jul-Aug;9(4):244-6. doi: 10.1097/00130404-200307000-00005. Cancer J. 2003. PMID: 12967133 No abstract available.

10

Hormone therapy adjuvant to external beam radiotherapy for locally advanced prostate carcinoma: a complication-adjusted number-needed-to-treat analysis.

Jani AB, Kao J, Hellman S. Jani AB, et al. Cancer. 2003 Dec 1;98(11):2351-61. doi: 10.1002/cncr.11804. Cancer. 2003. PMID: 14635069 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters